Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.065 | 0.3 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |